Understanding peripheral arterial disease in the current era
Listen to this summary
The authors aim to address the underacknowledgment, underdiagnosis, and undertreatment of peripheral arterial disease (PAD) in the context of atherosclerotic cardiovascular disease, highlighting its increasing prevalence and significant mortality rates. They emphasize the need for improved recognition and interdisciplinary measures to enhance patient outcomes and advocate for better integration of preventive care and treatment strategies. This clinical series seeks to inform clinicians and policymakers about the global burden of PAD and effective approaches to manage it.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Lancet (London, England)
View all →Sep 22, 2026 · Lancet (London, England)
Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment
Sep 22, 2026 · Lancet (London, England)
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead
Sep 21, 2026 · Lancet (London, England)
Developing roadmaps for advancing practice, research, and policy in the arts and health
Sep 18, 2026 · Lancet (London, England)
Precision prevention and early detection: framework for a new clinical cancer control pathway
Sep 17, 2026 · Lancet (London, England)
Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial
Sep 13, 2026 · Lancet (London, England)
Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study
More in Nuclear Medicine
View all →Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 18, 2026 · Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
CMR and FDG PET/CT Imaging Phenotypes and their Association with Outcomes in Patients with Known or Suspected Myocarditis
Sep 14, 2026 · The New England journal of medicine
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


